Orchard Park Rehab & Living in Farmington, ME

Orchard Park Rehab & Living is a medicare and medicaid certified nursing home in Farmington, Maine. It is located in Franklin county at 107 Orchard St, Farmington, Maine 04938. You can reach out to the office of Orchard Park Rehab & Living via phone at (207) 778-4416. This skilled nursing facility has 38 federally certified beds with average occupancy rate of 47.37%. Its legal business name is North Country Associates, Inc and has the following ownership type - For Profit - Corporation.

Orchard Park Rehab & Living (Medicare CCN 205168) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1994 (30 years certified) and the last quality survey was conducted in June, 2019.

Name	Orchard Park Rehab & Living
Location	107 Orchard St, Farmington, Maine
Certified By	Medicare and Medicaid
No. of Certified Beds	38
Occupancy Rate	47.37%
Medicare ID (CCN)	205168
Legal Business Name	North Country Associates, Inc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Orchard Park Rehab & Living from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1942362116
Organization Name	NORTH COUNTRY ASSOCIATES, INC
Doing Business As	ORCHARD PARK LIVING CENTER
Address	107 Orchard St, Farmington, ME 04938
Phone Number	207-778-4416

News Archive

Is the health overhaul's individual mandate the law's 'linchpin'?

NPR explores this question, which is increasingly central to discussions about the sweeping measure's future. Meanwhile, The Boston Globe reports on the number of waivers given out by Massachusetts to state residents who sought an exemption from that state's requirement to have health insurance.

Leidos Holdings revenues decrease $1.32B to 17% in first quarter FY 2015

Leidos Holdings, Inc., a national security, health and engineering solutions company, today reported financial results for the first quarter of fiscal year 2015, which ended May 2, 2014.

PharmAthene announces lifting of clinical hold on proposed SparVax Phase II study

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration has lifted the clinical hold previously placed on a proposed Phase II study of SparVax, a next generation recombinant anthrax vaccine.

Spironolactone should be considered as a treatment option in hypertensive patients with DHF

Mineralocorticoid receptor antagonists should be considered as a treatment option in hypertensive patients with diastolic heart failure, said Professor Burkert Pieske presenting results today of the Aldosterone Receptor Blockade in Diastolic Heart Failure (Aldo-DHF) study at ESC Congress 2012.

Read more Medical News

› Verified 1 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Orchard Park Rehab & Living are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Orchard Park Rehab & Living give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Is the health overhaul's individual mandate the law's 'linchpin'?

NPR explores this question, which is increasingly central to discussions about the sweeping measure's future. Meanwhile, The Boston Globe reports on the number of waivers given out by Massachusetts to state residents who sought an exemption from that state's requirement to have health insurance.

Leidos Holdings revenues decrease $1.32B to 17% in first quarter FY 2015

Leidos Holdings, Inc., a national security, health and engineering solutions company, today reported financial results for the first quarter of fiscal year 2015, which ended May 2, 2014.

PharmAthene announces lifting of clinical hold on proposed SparVax Phase II study

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration has lifted the clinical hold previously placed on a proposed Phase II study of SparVax, a next generation recombinant anthrax vaccine.

Spironolactone should be considered as a treatment option in hypertensive patients with DHF

Mineralocorticoid receptor antagonists should be considered as a treatment option in hypertensive patients with diastolic heart failure, said Professor Burkert Pieske presenting results today of the Aldosterone Receptor Blockade in Diastolic Heart Failure (Aldo-DHF) study at ESC Congress 2012.

Read more Medical News

› Verified 1 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	1
Total Amount of Fines in Dollars	$650
Number of Payment Denials	0
Total Number of Penalties	1

The resident survey data of Orchard Park Rehab & Living is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	26.23	14.46
Percentage of long-stay residents who lose too much weight	6.9	5.51